Admenta UK Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Admenta UK Limited - overview
Established
1929
Location
Coventry, -, UK
Primary Industry
Pharmaceuticals
About
Admenta UK Limited, based in Coventry, UK, operates as a healthcare distribution company, delivering vital medical supplies and services to enhance operational efficiency across various healthcare sectors. Admenta UK Limited is a healthcare distribution company focused on delivering medical supplies. Founded in 1929 in Coventry, UK, it was recently acquired by Aurelius Equity Opportunities in November 2021 for GBP 477 million from McKesson Corporation. The company specializes in delivering innovative solutions tailored to meet the specific needs of its diverse clientele.
Its core product offerings include advanced technology platforms designed for efficiency and scalability, which address critical challenges in various industries. These products are utilized primarily by businesses in sectors such as healthcare, finance, and manufacturing, aiming to streamline operations, enhance data management, and improve overall productivity. The company has strategically launched these products in key geographical markets, including North America, Europe, and Asia-Pacific, ensuring broad accessibility to its end users. By focusing on customizable solutions, the company serves a wide range of customers, from small enterprises to large corporations, all seeking to leverage technology for competitive advantage.
The company's revenue model is structured around B2B transactions, primarily facilitating partnerships and direct sales to clients across various industries. Clients typically engage with the company through subscription-based services, enabling them to access its flagship products on a recurring basis. Transactions are characterized by tailored pricing plans that reflect the specific needs and scale of each client's operations. For instance, clients may opt for tiered subscription models that provide varying levels of access to premium features and support services.
This direct engagement with businesses positions the company to capitalize on long-term relationships, fostering customer loyalty and driving sustained revenue growth. The revenue for the most recent year was GBP 0 mn. Following the recent acquisition by Aurelius Equity Opportunities, Admenta UK Limited plans to invest in and expand its business divisions. While specific upcoming products are not detailed, the company is focused on growth in its existing markets and potentially new geographic regions.
Recent funding will support these initiatives, reinforcing their operational capabilities and market reach.
Current Investors
Aurelius Group
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Drug Stores/Convenience Stores, Emergency Services, Home Healthcare, Nursing Homes & Assisted Living, Pharmaceuticals
Website
www.mckesson.uk
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Admenta UK Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Admenta UK Limited | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.